Search This Blog

Thursday, May 2, 2024

Pulmonx strong quarter on market growth

 

  • Revenue: $18.9 million in Q1 2024, a 30% increase year-over-year.

  • Gross Margin: Improved to 75% in Q1 2024 from 73% in the previous year.

  • Net Loss: Reduced to $13.7 million in Q1 2024 from $15.9 million year-over-year.

  • Earnings Per Share (EPS): Loss of $0.36 per share in Q1 2024, improved from a loss of $0.42 per share in the same period last year.

  • Operating Expenses: Increased to $28.6 million in Q1 2024 from $27 million in Q1 2023.

  • Adjusted EBITDA Loss: Reduced to $8 million in Q1 2024 from $11.2 million in Q1 2023.

  • Cash Position: Ended Q1 2024 with $120.4 million in cash, cash equivalents, and marketable securities.

  • Full Year Revenue Guidance: Reiterated at $81 million to $84 million for 2024.

  • Store Locations: Added 9 new Zephyr Valve centers in the U.S., total now 346.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.